Skip to main content
lexblog.com/lib/YSS4X4GKviewrecordjson
LEX-WK-YSS4X4GKcrawled 2025-04-07 12:13Z

Interpretation of the Anti-Monopoly Guidelines for Pharmaceutical Sector: Key Risk Considerations

Hao Zhan · Ying Song · Ruichen Liu · China Law Vision · Published April 7, 2025

Work details

firm or organization
AnJie Broad Law Firm
publication
China Law Vision
published
2025-04-07

Citation

Hao Zhan, Ying Song, Ruichen Liu, Interpretation of the Anti-Monopoly Guidelines for Pharmaceutical Sector: Key Risk Considerations, China Law Vision (April 7, 2025) [The Library at LexBlog, LEX-WK-YSS4X4GK, lexpid.org/YSS4X4GK]